Get the Stockscreener App
7.33
0.96%
0.07
After Hours:
7.35
0.02
+0.27%
Profound Medical Corp stock is traded at $7.33, with a volume of 594.48K.
It is up +0.96% in the last 24 hours and up +12.77% over the past month.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.
See More
Previous Close:
$7.26
Open:
$7.14
24h Volume:
594.48K
Relative Volume:
7.44
Market Cap:
$266.35M
Revenue:
$18.81M
Net Income/Loss:
$-38.90M
P/E Ratio:
-5.8753
EPS:
-1.2476
Net Cash Flow:
$-38.83M
1W Performance:
+7.64%
1M Performance:
+12.77%
6M Performance:
-5.54%
1Y Performance:
+29.05%
1-Day Range:
$7.07
$7.78
1-Week Range:
$6.625
$7.78
52-Week Range:
$3.76
$8.95
Profound Medical Corp Stock (PROF) Company Profile
Name
Profound Medical Corp
Sector
Industry
Phone
647-476-1350
Address
2400 SKYMARK AVENUE, UNIT 6, MISSISSAUGA, ON
Compare PROF vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PROF
Profound Medical Corp
|
7.33 | 263.81M | 18.81M | -38.90M | -38.83M | -1.2476 |
ABT
Abbott Laboratories
|
104.49 | 179.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
336.74 | 126.60B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
84.22 | 106.51B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
45.51 | 65.77B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
83.04 | 47.58B | 6.30B | 1.07B | 1.09B | 1.8406 |
Profound Medical Corp Stock (PROF) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-23-24 | Initiated | Lake Street | Buy |
| Jul-16-24 | Upgrade | Stifel | Hold → Buy |
| Nov-28-23 | Initiated | Stifel | Hold |
| Aug-04-23 | Downgrade | Raymond James | Strong Buy → Outperform |
| Mar-21-23 | Downgrade | Jefferies | Buy → Hold |
| Sep-15-20 | Initiated | Jefferies | Buy |
View All
Profound Medical Corp Stock (PROF) Latest News
Profound Medical Corp (PROF) Cash Flow - TradingKey
Profound Medical stock upgraded to Strong Buy on trial data, reimbursement outlook - Investing.com Canada
Robotic Radical Prostatectomy Comes Up 'Short' in CAPTAIN Trial - marketscreener.com
Why Profound Medical Corp stock surged yesterday - Wealth Awesome
Profound Medical Corp (PROF) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Profound Medical Corp (PROF) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
PROF|Profound Medical Corp|Price:7.350|Chg%:+0.090 - TradingKey
Profound Medical Market Sentiment - Benzinga España
Profound Medical Corp (PROF) Income Statement - TradingKey
Profound Medical Corp (PROF) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Profound Medical Corp Revenue Breakdown – TSX:PRN - TradingView
Profound Medical Corp. (PRN.TO) Stock: Advances as Study Shows TULSA Outperforms Robotic Surgery on Key Quality-of-Life Measures - Blockonomi
Why Profound Medical Corp stock is rising today - Wealth Awesome
Profound Medical Highlights New TULSA Quality-of-Life Data - TipRanks
Profound Medical (NASDAQ: PROF) shares CAPTAIN TULSA penile length data - Stock Titan
Robotic Radical Prostatectomy Comes Up ‘Short’ in CAPTAIN Trial - The Manila Times
Profound Medical Corp (PROF) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
What's Going On With Profound Medical Corp Stock Wednesday? - Wealth Awesome
Discipline and Rules-Based Execution in PROF Response - Stock Traders Daily
Why Profound Medical Corp stock is sliding today - Wealth Awesome
Profound Medical Corp. (PROF) Rises 1.03%: Support and Resistance Levels in FocusBackspread Trade - dars.gov.et
Profound Medical to Release Second Quarter 2026 Financial Results on August 6thConference Call to Follow - Investing News Network
Profound Medical to release Q2 2026 results on August 6 - scanx.trade
Profound Medical to report Q2 2026 results Aug. 6; conference call at 4:30 p.m. ET - TradingView
Profound Medical (NASDAQ: PROF) plans Q2 2026 financial results release and call - Stock Titan
Profound Medical Management to Review Q2 Results Aug. 6 - Stock Titan
What's Going On With Profound Medical Corp Stock Thursday? - Wealth Awesome
Profound Medical Corp. - Baystreet.ca
Stocks in play: Profound Medical Corp. - Yahoo! Finance Canada
Profound Medical to Highlight TULSA Procedure at SRS2026, Multiple Presentations and Investor Session - TradingView
Profound Medical (NASDAQ: PROF) plans strong TULSA presence at SRS2026 - Stock Titan
Profound Medical: Autonomous Robotics and Incisionless Surgery to Have Exceptional Presence at SRS2026 - The Manila Times
Why Profound Medical Corp stock is skyrocketing today - Wealth Awesome
Profound Medical (PROF) Moves 8.2% Higher: Will This Strength Last? - Yahoo Finance
Profound Medical Corp. (PROF) Edges Higher as Support Holds Near $6.50Put Dominated - dars.gov.et
Price to earnings forward of Profound Medical Corp – TSX:PRN - TradingView
Profound Medical (PROF) Stock Analysis Report | Ratings, Financials & Performance - Benzinga España
Profound Medical Corp. (PROF) Edges Higher: Testing Key Resistance Near $6.92FRAMA Signal - dars.gov.et
Behavioral Patterns of PROF and Institutional Flows - Stock Traders Daily
Profound Medical Corp. (PROF) Edges Higher, Testing Resistance After Support HoldEnding Diagonal - dars.gov.et
PROF Forecast — Price Target — Prediction for 2027 - TradingView
Profound Medical Corp Actuals & Estimates (NASDAQ:PROF) - TradingView
PRN Forecast — Price Target — Prediction for 2027 - TradingView
Grow Funds Small Cap Fund Outperforms Benchmarks in Q1 2026 - HarianBasis.co
Profound Medical Corp. (PROF) Dropped Despite High Potential - Insider Monkey
Profound Medical Corp (PROF) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Profound Medical Corp (PROF) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
PROF Q1 2026 Earnings: Surprise EPS Beat Drives Positive Stock ReactionNext Quarter Guidance - dars.gov.et
Why Profound Medical Corp stock is gaining today - Wealth Awesome
Bronstein, Gewirtz & Grossman, LLC Is Investigating Profound Medi - The National Law Review
PROF Q1 2026 Earnings: Narrower-Than-Expected Loss Beats EstimatesTrough Earnings Signal - newsline.com
Profound Medical Corp Stock (PROF) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.79%
4.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):